ResearcherUniversidad Francisco de VitoriaActive in the last 2 years
Alberto Orta
Matched on OpenAlex author ID A5042398262. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations. Co-author DOI 10.3389/fphar.2026.1868595↗
- A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. Co-author DOI 10.3390/jcm11247310↗
- The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer. Co-author DOI 10.3390/jcm9051252↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jesús García‐Foncillas · 3 shared papers, 2020–2026 · strength 0.58
- Paper Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, … DOI 10.3389/fphar.2026.1868595↗
- Paper A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. DOI 10.3390/jcm11247310↗
- Paper The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer. DOI 10.3390/jcm9051252↗
- Javier Martínez‐Useros · 3 shared papers, 2020–2026 · strength 0.58
- Paper Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, … DOI 10.3389/fphar.2026.1868595↗
- Paper A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. DOI 10.3390/jcm11247310↗
- Paper The Clinical Significance of PIWIL3 and PIWIL4 Expression in Pancreatic Cancer. DOI 10.3390/jcm9051252↗
- Carlos Lacalle-González · 1 shared paper, 2026 · strength 0.33
- Nuria Garcia-Carbonero · 2 shared papers, 2020–2022 · strength 0.25
- Weiyao Li · 2 shared papers, 2020–2022 · strength 0.25
- Roberto Pazo-Cid · 1 shared paper, 2022 · strength 0.14
- María Jesús Fernández‐Aceñero · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.